Skip to content

A study of the factor related to life-prolongation of patients with Duchenne muscular dystrophy

A study of the factor related to life-prolongation of patients with Duchenne muscular dystrophy - A study of the factor related to life-prolongation of DMD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016688
Enrollment
300
Registered
2015-03-03
Start date
2015-03-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy

Interventions

None listed

Sponsors

National Hospital Organization
Lead Sponsor
National Center of Neurology and Psychiatry
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Genetically confirmed as Duchenne muscular dystrophy No limitation of disease stage. No limitation of general condition. No limitation of organ function (motor function, respiratory failure, cardiac failure, and dysphagia). Patients with written informed consent. In case of unable to make decision because of the age under 16 years or mental retardation, patient with written informed consent by parents or legal guardian.

Exclusion criteria

Exclusion criteria: Subject meets any of the following criteria is not enrolled in the study. Not confirmed the diagnosis of DMD. Subject considered to be an unsuitable candidate for the study by the Principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Time to death

Secondary

MeasureTime frame
Time at loss of ambulation

Countries

Japan

Contacts

Public ContactToshio Saito

National Hospital Organization Osaka Toneyama Medical Center Clinical research center

saitot@toneyama.go.jp06-6853-2001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026